The effect of cytokines on the activation-induced apoptosis of B cells in autoimmune NZB x NZW F1 mice.
Programmed cell death (apoptosis) is an essential process in the development of various tissues and its involvement has been proposed for the elimination of self-reactive immature T and B lymphocytes when self antigens are first encountered. In order to further investigate the role of apoptosis in the pathogenesis of autoimmune disease, the apoptosis of lipopolysaccharide (LPS)-activated B cells, peritoneal cells from NZB x NZW F1 (NZB/W F1) mice and nonautoimmune BALB/c mice were assayed using an in vitro culture system. Splenic B cells were isolated and then stimulated with LPS before further activated with crosslinking antimu antibody. In addition, the apoptosis of peritoneal cells induced by crosslinking antimu antibody was also analyzed. The data revealed that the specific apoptosis of both activated B cells and peritoneal cells induced by crosslinking antimu antibody was very similar comparing NZB/W F1 and nonautoimmune BALB/c mice. This activation-induced B-cells apoptosis could be rescued, however, with the addition of cytokines such as interleukin (IL)-5 or IL-10, to the culture. The results suggest that there is no endogenous defect in the apoptosis of activated B cells for autoimmune NZB/W F1 comparing nonautoimmune BALB/c mice. Notably, however, abnormally high levels of the type 2 T helper (Th2)-related cytokines such as IL-5 or IL-10 may play an important role in the abnormal expansion of activated B cells in autoimmune NZB/W F1 mice.
Chen
Y Y
YY
Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Suen
J L
JL
Wu
W M
WM
Chiang
B L
BL
D000818:Animals; D000906:Antibodies / Q000276:immunology; D017209:Apoptosis; D001402:B-Lymphocytes / Q000166:cytology*; D002478:Cells, Cultured; D016207:Cytokines / Q000494:pharmacology*; D005260:Female; D007075:Immunoglobulin M / Q000276:immunology; D016753:Interleukin-10 / Q000494:pharmacology; D015848:Interleukin-5 / Q000494:pharmacology; D008070:Lipopolysaccharides / Q000494:pharmacology; D008180:Lupus Erythematosus, Systemic / Q000473:pathology*; D008213:Lymphocyte Activation; D051379:Mice; D008807:Mice, Inbred BALB C; D008814:Mice, Inbred NZB; D010529:Peritoneal Cavity / Q000166:cytology
D000906:Antibodies; D016207:Cytokines; D007075:Immunoglobulin M; D015848:Interleukin-5; D008070:Lipopolysaccharides; D016753:Interleukin-10